IAIM
GNOM icon

International Assets Investment Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

International Assets Investment Management’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-188
Closed -$7.83K – 2086
2024
Q2 		$7.83K Buy
+188
New +$7.86K ﹤0.01% 1737

Other funds holding GNOM

OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

International Assets Investment Management's GNOM Position: Q3 2024 in Review

International Assets Investment Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2024, closing a stake of 188 shares — an estimated $7.83K sold.

International Assets Investment Management first reported a position in GNOM in Q2 2024 and held it in 1 quarter. The position peaked at $7.83K in Q2 2024. 65 funds tracked by Wall St. Rank hold GNOM as of Q3 2024.

  • International Assets Investment Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2024 after selling out during the quarter.
  • International Assets Investment Management sold 188 Global X Genomics & Biotechnology ETF shares in Q3 2024, an estimated $7.83K.
  • International Assets Investment Management first reported a position in Global X Genomics & Biotechnology ETF in Q2 2024 and held it in 1 quarter.
  • International Assets Investment Management's Global X Genomics & Biotechnology ETF position peaked at $7.83K in Q2 2024.
  • 65 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2024.

Based on International Assets Investment Management's 13F filing for Q3 2024, filed 22 Oct 2024.